STTK Stock Analysis: Buy, Sell, or Hold?
STTK - Shattuck Labs, Inc. Common Stock
$6.26
-0.41 (-6.15%)
▼
5d:
-8.61%
30d:
-14.83%
90d:
+62.18%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When STTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: STTK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: STTK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: STTK is currently trading at $6.26, which is considered oversold relative to its 30-day fair value range of $6.63 to $7.57.
Technical Outlook: Technically, STTK is in a strong uptrend. Immediate support is located at $5.95, while resistance sits at $7.37. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.50 (+99.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STTK is in a strong uptrend. Immediate support is located at $5.95, while resistance sits at $7.37. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.50 (+99.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.63 -
$7.57
Company Quality Score
59/100
(HOLD)
Options IV Signal
19th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
82.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 19th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.1%)
- BULLISH: Trading 99.7% below Wall St target ($12.50)
- CAUTION: Recommendation downgraded due to -8.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$6.63 -
$7.57
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.98
(15.7%)
Support & Resistance Levels
Support Level
$5.95
Resistance Level
$7.37
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.24
Wall Street Target
$12.50
(+99.7%)
Revenue Growth (YoY)
-66.6%
Share & Embed Analysis
Last updated: May 18, 2026 6:03 AM ET
Data refreshes hourly during market hours. Next update: 7:03 AM
Data refreshes hourly during market hours. Next update: 7:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 53 HOLD |
